Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Establishment Labs Holdings Inc (NQ: ESTA )

45.42 +2.33 (+5.41%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Establishment Labs Holdings Inc

< Previous 1 2 3 4 Next >
Establishment Labs Announces Three-Year Mia Femtech Clinical Results at 9th World Symposium on Ergonomic Implants
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Third Quarter 2024 Financial Results on November 7
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Publishes 2024 Post Market Surveillance Report
From Establishment Labs Holdings Inc.
Via Business Wire
First U.S. Women Successfully Receive Breast Augmentation with New FDA Approved Motiva Implants
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Receives U.S. FDA Approval for Motiva Implants
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Second Quarter 2024 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Second Quarter 2024 Financial Results on August 6
From Establishment Labs Holdings Inc.
Via Business Wire
Findell Capital Management LLC Releases Comprehensive Research Coverage Report on Nasdaq:ESTA
Via Get News
Exposures Product Safety
Findell Capital Management LLC Releases Comprehensive Research Coverage Report on ESTA: Nasdaq
New York, NY, June 17, 2024 – Findell Capital Management LLC, an investment management firm, today announced the release of a detailed Report on Establishment Labs Holdings Inc. (Nasdaq: ESTA), which... 
Via TheNewswire.com
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports First Quarter 2024 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Notes Presentation of 4-Year Results from Motiva U.S. IDE Study at The Aesthetic Meeting 2024
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Appointment of Jeff Ehrhardt as General Manager of North America
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce First Quarter 2024 Financial Results on May 8
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Participation in The Aesthetic Meeting 2024
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Guidance
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Amended Credit Facility with Oaktree
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Fourth Quarter 2023 Financial Results on February 28
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Commercial Launch of Motiva Implants in China
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces $50 Million Private Placement and Preliminary Unaudited Financial Results for the Fourth Quarter and Fiscal Year 2023
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces First U.S. Commercial Procedure with Motiva Flora Tissue Expander
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Present at the 42nd Annual J.P. Morgan Healthcare Conference
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Participation in Two Upcoming Investment Conferences
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces National Medical Products Administration Approval for Motiva Implants in China
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Third Quarter 2023 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs to Announce Third Quarter 2023 Financial Results on November 7
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces FDA Clearance of Motiva Flora SmoothSilk Tissue Expander
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Announces Two-Year Mia Femtech Clinical Results and the Launch of Zen at 8th World Symposium on Ergonomic Implants
From Establishment Labs Holdings Inc.
Via Business Wire
Establishment Labs Reports Record Second Quarter 2023 Financial Results
From Establishment Labs Holdings Inc.
Via Business Wire
< Previous 1 2 3 4 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.